ARQTArcutis Biotherapeutics, Inc.
$31.21+49% 1Y
$31.21
$19.5052 weeks$32.80
Who owns ARQT
268 institutions reported holding ARQT for 2026Q2, together 101% of the company, more than the 265 a quarter earlier.
268
Institutions reporting a position · as of 2026Q2 · up from 265 the quarter before
- Shares held by institutions
- 131.1M
Shares held by institutions · 101% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $3.44B
Reported value · at Jun 30, 2026 prices, not today's
- Top 5 holders
- 38%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-06-30
- 2026Q2
- Quarters on record
- 26
- New positions
- 42
- Positions exited
- 40
- Added to
- 87
- Reduced
- 95
- Top 10 holdersof the company
- 58%
- Shares sold shortsettled Sep 30, 2026
- 21.7M
- Short interestof shares outstanding
- 17%
- Days to coverat the average daily volume
- 4.8
- Change in the short positionsince the Sep 15, 2026 count
- +18%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q2 | 268 | 131.1M | $3.44B |
| 2026Q1 | 265 | 132.0M | $3.11B |
| 2025Q4 | 278 | 128.9M | $3.74B |
| 2025Q3 | 236 | 125.6M | $2.37B |
| 2025Q2 | 225 | 126.7M | $1.78B |
| 2025Q1 | 239 | 125.7M | $1.97B |
| 2024Q4 | 205 | 128.8M | $1.79B |
| 2024Q3 | 184 | 128.1M | $1.19B |
| 2024Q2 | 184 | 125.9M | $1.17B |
| 2024Q1 | 167 | 125.0M | $1.24B |
| 2023Q4 | 133 | 101.3M | $327M |
| 2023Q3 | 133 | 67.2M | $357M |
| 2023Q2 | 135 | 71.8M | $684M |
| 2023Q1 | 141 | 71.5M | $787M |
| 2022Q4 | 141 | 66.1M | $980M |
| 2022Q3 | 138 | 59.4M | $1.13B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 12.4M | 9.6% | $326M |
| BlackRock Inc. | 10.5M | 8.2% | $277M |
| Frazier Life Sciences Management, L.P. | 9.9M | 7.6% | $259M |
| VANGUARD GROUP INC | 8.4M | 6.5% | $220M |
| Rubric Capital Management LP | 8.3M | 6.4% | $217M |
| Polar Capital Holdings Plc | 6.6M | 5.1% | $173M |
| STATE STREET CORP | 5.8M | 4.5% | $153M |
| MORGAN STANLEY | 4.5M | 3.4% | $117M |
| JENNISON ASSOCIATES LLC | 4.2M | 3.3% | $111M |
| D. E. Shaw & Co., INC. | 3.9M | 3.1% | $104M |
| Settlement | Shares short | Of shares outstanding | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 21.7M | 17% | 4.8 |
| Sep 15, 2026 | 18.5M | 15% | 8.5 |
| Aug 31, 2026 | 16.6M | 13% | 9.4 |
| Aug 14, 2026 | 14.7M | 12% | 8.0 |
| Jul 31, 2026 | 12.7M | 10% | 10.7 |
| Jul 15, 2026 | 13.6M | 11% | 9.3 |
| Jun 30, 2026 | 14.0M | 11% | 6.3 |
| Jun 15, 2026 | 15.8M | 13% | 10.0 |
| May 29, 2026 | 16.2M | 13% | 8.4 |
| May 15, 2026 | 17.5M | 14% | 7.3 |
| Apr 30, 2026 | 16.9M | 13% | 16.6 |
| Apr 15, 2026 | 16.6M | 13% | 15.6 |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold. The short position is FINRA's consolidated count for each twice-monthly settlement date, as a share of shares outstanding.
opening the register…
On our screens:Stocks with no debtQuality compoundersQuality at a reasonable priceStocks priced for perfectionand 1 more